Network-targeted neurophysiological biomarkers of dysconnectivity and cognitive decline in Alzheimer’s disease
These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD.